<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" 
  xmlns:dc="http://purl.org/dc/elements/1.1/"
  xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
  xmlns:admin="http://webns.net/mvcb/"
  xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">

<channel>
<title>In the Pipeline</title>
<link>/home/corante/public_html/pipeline/</link>
<description></description>
<dc:language>en-us</dc:language>
<dc:creator>derekb.lowe@gmail.com</dc:creator>
<dc:date>2012-01-26T07:31:12-05:00</dc:date>
<admin:generatorAgent rdf:resource="http://www.movabletype.org/?v=3.34" />
<sy:updatePeriod>hourly</sy:updatePeriod>
<sy:updateFrequency>1</sy:updateFrequency>
<sy:updateBase>2000-01-01T12:00+00:00</sy:updateBase>

<item>
<title>Putting a Number on Chemical Beauty</title>
<link>http://pipeline.corante.com/archives/2012/01/26/putting_a_number_on_chemical_beauty.php</link>
<description>There&apos;s a new paper out in Nature Chemistry called &quot;Quantifying the Chemical Beauty of Drugs&quot;. The authors are proposing a new &quot;desirability score&quot; for chemical structures in drug discovery, one that&apos;s an amalgam of physical and structural scores. To their...</description>
<guid isPermaLink="false">75405@/home/corante/public_html/pipeline/</guid>
<dc:subject>Life in the Drug Labs</dc:subject>
<dc:date>2012-01-26T07:31:12-05:00</dc:date>
</item>
<item>
<title>A Look Into the Future?</title>
<link>http://pipeline.corante.com/archives/2012/01/09/a_look_into_the_future.php</link>
<description>For a look into a possible drug-discovery future (from the computational optimist viewpoint), you might want to check out a brief bit of science fiction, &quot;Alpha Shock&quot;, in the Journal of Computer-Aided Molecular Design. Some excerpts to give you the...</description>
<guid isPermaLink="false">75369@/home/corante/public_html/pipeline/</guid>
<dc:subject>In Silico</dc:subject>
<dc:date>2012-01-09T08:40:55-05:00</dc:date>
</item>
<item>
<title>Where&apos;s the Best Place to Apply Modeling to Drug Discovery?</title>
<link>http://pipeline.corante.com/archives/2011/11/07/wheres_the_best_place_to_apply_modeling_to_drug_discovery.php</link>
<description>An e-mail correspondent and I were discussing this question, and I thought it would be an interesting one for everyone. He&apos;s a computational guy, and he&apos;s been wondering where the best use of computation/modeling effort in drug research might be....</description>
<guid isPermaLink="false">75263@/home/corante/public_html/pipeline/</guid>
<dc:subject>In Silico</dc:subject>
<dc:date>2011-11-07T13:10:40-05:00</dc:date>
</item>
<item>
<title>Foldit Notches a Protein Structure Success (And Some Failures)</title>
<link>http://pipeline.corante.com/archives/2011/09/20/foldit_notches_a_protein_structure_success_and_some_failures.php</link>
<description>I wrote last year about Foldit, a collaborative effort to work on protein structure problems that&apos;s been structured as an open-access game. Now the team is back with another report on how the project is going, and it&apos;s interesting stuff....</description>
<guid isPermaLink="false">75184@/home/corante/public_html/pipeline/</guid>
<dc:subject>In Silico</dc:subject>
<dc:date>2011-09-20T07:22:24-05:00</dc:date>
</item>
<item>
<title>Design a Molecule, Win an IPad (Which is More Than You Usually Get)</title>
<link>http://pipeline.corante.com/archives/2011/08/26/design_a_molecule_win_an_ipad_which_is_more_than_you_usually_get.php</link>
<description>For those of you who are (or have always wanting to try being) molecular modelers, Cresset Design is holding a contest you might enjoy. They&apos;re putting up a molecule and giving out temporary licenses to their modeling software, and inviting...</description>
<guid isPermaLink="false">75153@/home/corante/public_html/pipeline/</guid>
<dc:subject>In Silico</dc:subject>
<dc:date>2011-08-26T07:03:59-05:00</dc:date>
</item>
<item>
<title>Modeling and Structure</title>
<link>http://pipeline.corante.com/archives/2011/03/29/modeling_and_structure.php</link>
<description>Man, am I getting all kinds of comments (here and by e-mail) about my views on modeling, QSAR, and the like. I thought it might be helpful for me to clarify my position on these things. First off, structure. It&apos;s...</description>
<guid isPermaLink="false">74925@/home/corante/public_html/pipeline/</guid>
<dc:subject>In Silico</dc:subject>
<dc:date>2011-03-29T11:23:48-05:00</dc:date>
</item>
<item>
<title>Value in Structure?</title>
<link>http://pipeline.corante.com/archives/2011/03/28/value_in_structure.php</link>
<description>A friend on the computational/structural side of the business sent along this article from Nature Reviews Drug Discovery. The authors are looking through the Thomson database at drug targets that are the subject of active research in the industry, and...</description>
<guid isPermaLink="false">74923@/home/corante/public_html/pipeline/</guid>
<dc:subject>In Silico</dc:subject>
<dc:date>2011-03-28T06:20:32-05:00</dc:date>
</item>
<item>
<title>Maybe We Should Make It More of a Game</title>
<link>http://pipeline.corante.com/archives/2010/08/09/maybe_we_should_make_it_more_of_a_game.php</link>
<description>David Baker&apos;s lab at the University of Washington has been working on several approaches to protein structure problems. I mentioned Rosetta@home here, and now the team has published an interesting paper on another one of their efforts, FoldIt. That one,...</description>
<guid isPermaLink="false">74613@/home/corante/public_html/pipeline/</guid>
<dc:subject>In Silico</dc:subject>
<dc:date>2010-08-09T08:53:00-05:00</dc:date>
</item>
<item>
<title>Free Software</title>
<link>http://pipeline.corante.com/archives/2010/06/22/free_software.php</link>
<description>The folks at Cresset sent me a note about a free download of some software that they&apos;ve developed for molecular fields (an approach you can read more about here). Fieldview is a free tool for trying this out yourself, and...</description>
<guid isPermaLink="false">74543@/home/corante/public_html/pipeline/</guid>
<dc:subject>In Silico</dc:subject>
<dc:date>2010-06-22T12:43:02-05:00</dc:date>
</item>
<item>
<title>What Has Bioinformatics Ever Done For Us?</title>
<link>http://pipeline.corante.com/archives/2010/06/18/what_has_bioinformatics_ever_done_for_us.php</link>
<description>A reader points me to this discussion, which is trying to figure out what the most useful discovery made via bioinfomatics is so far. There&apos;s a $100 prize for the winning suggestion, just to keep the discussion moving (and no,...</description>
<guid isPermaLink="false">74536@/home/corante/public_html/pipeline/</guid>
<dc:subject>In Silico</dc:subject>
<dc:date>2010-06-18T06:31:55-05:00</dc:date>
</item>
<item>
<title>Modeling in Drug Discovery: Questions?</title>
<link>http://pipeline.corante.com/archives/2010/05/17/modeling_in_drug_discovery_questions.php</link>
<description>I&apos;ll have the opportunity to sit in on a few talks during a conference on free energy calculations in drug design. Since I&apos;m not a computational guy myself, I&apos;ll be picking my sessions carefully, but I am interested in hearing...</description>
<guid isPermaLink="false">74472@/home/corante/public_html/pipeline/</guid>
<dc:subject>In Silico</dc:subject>
<dc:date>2010-05-17T06:32:43-05:00</dc:date>
</item>
<item>
<title>Unlovely Polyphenols</title>
<link>http://pipeline.corante.com/archives/2010/05/10/unlovely_polyphenols.php</link>
<description>Here&apos;s a new paper from the folks at the Burnham Institute and UCSD on a new target for vaccinia virus. They&apos;re going after a virulence factor (N1L) through computational screening, which is a challenge, since this is a protein-protein interaction....</description>
<guid isPermaLink="false">74461@/home/corante/public_html/pipeline/</guid>
<dc:subject>Infectious Diseases</dc:subject>
<dc:date>2010-05-10T10:20:47-05:00</dc:date>
</item>
<item>
<title>Bill Gates Put Some Money On Schrödinger</title>
<link>http://pipeline.corante.com/archives/2010/05/10/bill_gates_put_some_money_on_schrodinger.php</link>
<description>My take on the recent news that Bill Gates has invested ten million dollars in the computational drug design company Schrödinger is here at Nature News. (They&apos;ve recently made all their stories open-access, by the way, so you don&apos;t need...</description>
<guid isPermaLink="false">74460@/home/corante/public_html/pipeline/</guid>
<dc:subject>In Silico</dc:subject>
<dc:date>2010-05-10T07:52:20-05:00</dc:date>
</item>
<item>
<title>Another Proposal For the Scientific Literature</title>
<link>http://pipeline.corante.com/archives/2010/05/04/another_proposal_for_the_scientific_literature.php</link>
<description>I was talking with a colleague yesterday, and I suddenly had an insight into an opportunity in scientific publishing. We were discussing the various computational/modeling papers that you see out in the literature. Some of them are quite interesting, many...</description>
<guid isPermaLink="false">74443@/home/corante/public_html/pipeline/</guid>
<dc:subject>The Scientific Literature</dc:subject>
<dc:date>2010-05-04T10:09:51-05:00</dc:date>
</item>
<item>
<title>Compounds and Proteins</title>
<link>http://pipeline.corante.com/archives/2010/03/29/compounds_and_proteins.php</link>
<description>For the medicinal chemists in the audience, I wanted to strongly recommend a new paper from a group at Roche. It&apos;s a tour through the various sorts of interactions between proteins and ligands, with copious examples, and it&apos;s a very...</description>
<guid isPermaLink="false">74370@/home/corante/public_html/pipeline/</guid>
<dc:subject>Drug Assays</dc:subject>
<dc:date>2010-03-29T08:17:20-05:00</dc:date>
</item>


</channel>
</rss>
